We are live on ! Find out more
CERE

Cerevel Therapeutics Holdings, Inc. Common Stock
CERE

Delisted

CERE was delisted on the 31st of July, 2024.

Back to rankings

2 hedge funds and large institutions have $20.7K invested in Cerevel Therapeutics Holdings, Inc. Common Stock in 2024 Q3 according to their latest regulatory filings, with 0 funds opening new positions, 1 increasing their positions, 1 reducing their positions, and 228 closing their positions.

New
Increased
Maintained
Reduced
Closed

0% more repeat investments, than reductions

Existing positions increased: 1 | Existing positions reduced: 1

99% less funds holding

Funds holding: 231 → 2 (-229)

100% less funds holding in top 10

Funds holding in top 10: 16 → 0 (-16)

100% less capital invested

Capital invested by funds: $6.42B → $20.7K (-$6.42B)

100% less first-time investments, than exits

New positions opened: 0 | Existing positions closed: 228

Holders
2
Holders Change
-229
Holders Change %
-99.13%
% of All Funds
0.03%
Holding in Top 10
–
Holding in Top 10 Change
-16
Holding in Top 10 Change %
-100%
% of All Funds
–
New
–
Increased
1
Reduced
1
Closed
228
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
BTI
Blue Trust Inc
Georgia
+$297

Top Sellers

Rank Fund Capital Flow
1
BCI
Bain Capital Investors
Massachusetts
-$2.69B
2
PA
Perceptive Advisors
New York
-$441M
3
ACA
Avoro Capital Advisors
New York
-$308M
4
Vanguard Group
Vanguard Group
Pennsylvania
-$293M
5
BlackRock
BlackRock
New York
-$146M
Name Holding Trade Value Shares
Change 		Change in
Stake
IA
1
IFP Advisors
Florida
$15.5K -$17.7K -418 -55%
BTI
2
Blue Trust Inc
Georgia
$5.15K +$297 +7 +6%
BCI
3
Bain Capital Investors
Massachusetts
– -$2.69B -65,679,781 Closed
PA
4
Perceptive Advisors
New York
– -$441M -10,794,876 Closed
ACA
5
Avoro Capital Advisors
New York
– -$308M -7,539,547 Closed
Vanguard Group
6
Vanguard Group
Pennsylvania
– -$293M -7,154,343 Closed
BlackRock
7
BlackRock
New York
– -$146M -3,560,931 Closed
Fidelity International
8
Fidelity International
Bermuda
– -$133M -3,252,000 Closed
State Street
9
State Street
Massachusetts
– -$127M -3,109,886 Closed
AAM
10
Alpine Associates Management
Florida
– -$96.2M -2,353,694 Closed
Norges Bank
11
Norges Bank
Norway
– -$95.5M -2,335,746 Closed
PBA
12
Paradigm Biocapital Advisors
New York
– -$95.3M -2,330,508 Closed
SFM
13
Soros Fund Management
New York
– -$88M -2,151,641 Closed
Millennium Management
14
Millennium Management
New York
– -$82M -2,004,795 Closed
UOC
15
UBS O'Connor
Illinois
– -$81.8M -2,000,000 Closed
PCM
16
Pentwater Capital Management
Florida
– -$76.8M -1,878,719 Closed
Marshall Wace
17
Marshall Wace
United Kingdom
– -$76.4M -1,869,340 Closed
AllianceBernstein
18
AllianceBernstein
Tennessee
– -$61.1M -1,494,341 Closed
Geode Capital Management
19
Geode Capital Management
Massachusetts
– -$60.1M -1,469,670 Closed
Ameriprise
20
Ameriprise
Minnesota
– -$55.1M -1,347,680 Closed
Citigroup
21
Citigroup
New York
– -$52.5M -1,284,070 Closed
Qube Research & Technologies (QRT)
22
Qube Research & Technologies (QRT)
United Kingdom
– -$50.4M -1,233,565 Closed
FCM
23
Farallon Capital Management
California
– -$48.7M -1,190,000 Closed
LP
24
LMR Partners
United Kingdom
– -$46.3M -1,133,181 Closed
MAM
25
Melqart Asset Management
United Kingdom
– -$44.9M -1,099,229 Closed
1
2 3 4 5

CERE Hedge Fund Activity: Q3 2024 in Review

2 of the 6,964 institutional investors tracked by Wall St. Rank reported a position in Cerevel Therapeutics Holdings, Inc. Common Stock (CERE) for Q3 2024, worth a combined $20.7K — down 100% from $6.42B a quarter earlier.

Sellers outnumbered buyers: 228 funds closed out of CERE and 0 opened new positions — a net loss of 228 holders — while 1 trimmed existing stakes and 1 added.

The largest buyer was Blue Trust Inc, adding an estimated $297. The largest seller was Bain Capital Investors, exiting entirely with an estimated $2.69B sold.

  • 2 institutional investors held Cerevel Therapeutics Holdings, Inc. Common Stock (CERE) as of Q3 2024, down from 231 in Q2 2024.
  • Funds reported $20.7K of Cerevel Therapeutics Holdings, Inc. Common Stock stock for Q3 2024, down 100% quarter-over-quarter.
  • 0 funds opened new Cerevel Therapeutics Holdings, Inc. Common Stock positions in Q3 2024 and 228 closed out, a net change of -228 holders.
  • The largest Cerevel Therapeutics Holdings, Inc. Common Stock buyer in Q3 2024 was Blue Trust Inc, an estimated $297 added.
  • The largest Cerevel Therapeutics Holdings, Inc. Common Stock seller in Q3 2024 was Bain Capital Investors, an estimated $2.69B sold.

Based on aggregated 13F filings for Q3 2024.